Filed by the Registrant ☒ | Filed by a Party other than the Registrant ☐ | ||
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | Definitive Proxy Statement |
☐ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to § 240.14a-12 |
(Name of Registrant as Specified in its Charter) |
Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) |
☒ | No fee required. |
☐ | Fee paid previously with preliminary materials. |
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. |

1. | To elect Jon Cohen, Erez Shachar, and Madhu Pawar to serve as the Class I directors until the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified; |
2. | To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global, as the Company’s independent auditors for the fiscal year ending December 31, 2025; |
3. | To approve, on an advisory basis, the compensation of the Company’s named executive officers; and |
4. | To transact such other business as may properly come before the Annual Meeting or any continuation, postponement, or adjournment of the Annual Meeting. |
• | “we,” “us,” “our,” the “Company” and “Talkspace” refer to Talkspace, Inc., and, unless otherwise stated, all of its subsidiaries; |
• | “Business Combination” refers to the transactions contemplated by that certain Agreement and Plan of Merger, dated as of January 12, 2021 (the “Merger Agreement”), by and between Hudson Executive Investment Corp. (“HEC”), Groop Internet Platform, Inc. (“Old Talkspace”), Tailwind Merger Sub I, Inc., a Delaware corporation and a direct wholly owned subsidiary of HEC (“First Merger Sub”), and Tailwind Merger Sub II, LLC, a Delaware limited liability company (“Second Merger Sub”), including the mergers contemplated by the Merger Agreement whereby: (i) First Merger Sub merged with and into Old Talkspace (the “First Merger”) with Old Talkspace surviving the First Merger, and (ii) immediately following the First Merger and as part of the same overall transaction as the First Merger, Old Talkspace merged with and into Second Merger Sub, with Second Merger Sub surviving the merger as a wholly owned subsidiary of HEC (the “Second Merger”). |
1. | To elect Jon Cohen, Erez Shachar, and Madhu Pawar to serve as the Class I directors until the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified; |
2. | To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global, as the Company’s independent auditors for the fiscal year ending December 31, 2025; |
3. | To approve, on an advisory basis, the compensation of the Company’s named executive officers; and |
4. | To transact such other business as may properly come before the Annual Meeting or any continuation, postponement, or adjournment of the Annual Meeting. |
1. | FOR the proposal to elect Jon Cohen, Erez Shachar, and Madhu Pawar to serve until the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified; |
2. | FOR the proposal to ratify the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global, as the Company’s independent auditors for the fiscal year ending December 31, 2025; and |
3. | FOR the proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers. |
• | by Internet-You can vote over the Internet at www.proxyvote.com by following the instructions on the proxy card or on the instructions that accompanied your proxy materials; |
• | by Telephone-You can vote by telephone by calling 1-800-690-6903 and following the instructions on the proxy card; or |
• | by Mail-You can vote by mail by signing, dating and mailing the proxy card, which you may have received by mail. |
• | by submitting a duly executed proxy bearing a later date; |
• | by granting a subsequent proxy through the Internet or telephone; |
• | by giving written notice of revocation to the Secretary of Talkspace prior to the Annual Meeting; or |
• | by voting electronically at the Annual Meeting. |
Proposal | Votes required | Effect of Votes Withheld / Abstentions and Broker Non-Votes | ||||||
Proposal 1: Election of Directors | The plurality of the votes cast. This means that the three nominees receiving the highest number of affirmative “FOR” votes will be elected as Directors. | Votes withheld and broker non-votes will have no effect. | ||||||
Proposal 2: Ratification of Appointment of Independent Auditors | The affirmative vote of the holders of a majority in voting power of the votes cast on such matter. | Abstentions will have no effect on the outcome of the proposal. We do not expect any broker non-votes on this proposal. | ||||||
Proposal 3: Approval, on an advisory basis, of the compensation of the Company’s named executive officers (“Say on Pay”). | The affirmative vote of the holders of a majority in voting power of the votes cast on such matter. | Abstentions and broker non-votes will have no effect on the outcome of the proposal. | ||||||
![]() | The Board of Directors unanimously recommends a vote FOR the election of the below Director nominees. | ||
Name | Age | Served as a Director Since | Positions with Talkspace | ||||||
Jon Cohen | 71 | 2022 | Chief Executive Officer and Director | ||||||
Erez Shachar | 61 | 2021 | Director | ||||||
Madhu Pawar | 45 | 2021 | Director | ||||||
DR. JON COHEN, M.D. | Age 71 | ||
EREZ SHACHAR | Age 61 | ||
MADHU PAWAR | Age 45 | ||
Name | Age | Served as a Director Since | Positions with Talkspace | ||||||
Curtis Warfield | 57 | 2021 | Director | ||||||
Jacqueline Yeaney | 57 | 2021 | Director | ||||||
Michael Hansen | 64 | 2022 | Director | ||||||
CURTIS WARFIELD | Age 57 | ||
JACQUELINE YEANEY | Age 57 | ||
MICHAEL HANSEN | Age 64 | ||
Name | Age | Served as a Director Since | Positions with Talkspace | ||||||
Douglas Braunstein | 64 | 2021 | Director | ||||||
Swati Abbott | 62 | 2023 | Director | ||||||
Liat Ben-Zur | 48 | 2023 | Director | ||||||
DOUGLAS L. BRAUNSTEIN | Age 64 | ||
SWATI ABBOTT | Age 62 | ||
LIAT BEN-ZUR | Age 48 | ||
![]() | The Board of Directors unanimously recommends a vote FOR the ratification of the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global as the Company’s independent auditors. | ||
Fee Category | Fiscal 2023 | Fiscal 2024 | ||||
Audit Fees | $1,288 | $1,059 | ||||
Audit-Related Fees | $— | $— | ||||
Tax Fees | $35 | $18 | ||||
Total Fees | $1,323 | $1,077 | ||||
![]() | The Board of Directors unanimously recommends a vote FOR the approval, on an advisory basis, of the compensation of our named executive officers. | ||
Name | Age | Position | ||||
Jon Cohen(1) | 70 | Chief Executive Officer and Director | ||||
Ian Harris(2) | 36 | Chief Financial Officer | ||||
John C. Reilly(3) | 59 | Chief Legal Officer and Corporate Secretary | ||||
Gil Margolin(4) | 48 | Chief Technology Officer | ||||
Katelyn Watson(5) | 46 | Chief Marketing Officer | ||||
(1) | See biography on page 10 of this proxy statement. |
(2) | Mr. Harris has served as Talkspace’s Chief Financial Officer since May 2024. Prior to joining Talkspace, Mr. Harris most recently served as Partner and Managing Director at Hudson Executive Capital LP, an alternative investment firm. At Hudson Executive Capital, Mr. Harris led the investment team’s efforts to source, perform diligence, and manage investments in the healthcare, technology, and financial services sectors. Prior to joining Hudson Executive Capital in 2017, Mr. Harris worked at Barclays Capital, the investment banking division of Barclays PLC, where he advised healthcare companies on M&A and capital market activities. Mr. Harris currently serves as a director at Cantaloupe (Nasdaq: CTLP) and Liberated Syndication, Inc. Mr. Harris received a B.A. in Economics and a B.A. in International Relations from Brown University. |
(3) | Mr. Reilly has served as Talkspace’s Corporate and then General Counsel since March 2011 and presently serves as Talkspace’s Chief Legal Officer. Prior to joining Talkspace, Mr. Reilly was a partner of Hilltop Holdings from 2004-2011, where he managed hospitality and real estate investments for private portfolio investors and acted as a fractional general counsel to several start-up companies. Mr. Reilly previously served as President of Highland Development Corporation, a real estate development company, from 1999 to 2003 where he partnered to build and operate congregate care campuses. Mr. Reilly also previously held several roles at Kapson Senior Quarters Corp., a publicly traded assisted living company, including as Senior Vice President of Acquisitions and Development from 1998 to 1999, Vice President of Development from 1997 to 1998 and Corporate Counsel from 1996 to 1997. Mr. Reilly started his career as a legal associate at Squire, Sanders & Dempsey in Washington DC. Mr. Reilly holds a J.D. from Boston College Law School and a B.A. from the University of Virginia. |
(4) | Mr. Margolin has served as Talkspace’s Chief Technology Officer since April 2014. Prior to joining Talkspace, Mr. Margolin served as the Director of Product Management at Deutsche Telekom AG, a telecommunications company, from October 2012 to April 2014. Prior to that, Mr. Margolin served as Director of Product Management at SupportSpace, a cloud-based remote services company, from October 2011 to November 2012. Mr. Margolin previously held several roles at Amdocs, a software and services provider to communications and media companies, including as Director of Product Management from October 2009 to November 2011, Architecture Manager from 2007 to 2009, and Engineering Manager from 2004 to 2007. Mr. Margolin holds a B.S. in Computer Science from the University of Tel Aviv. |
(5) | Ms. Watson has served as the Chief Marketing Officer of Talkspace since October 2022. Prior to Talkspace, Ms. Watson served as the Chief Marketing Officer of Nurx (and then Thirty Madison following their acquisition of Nurx), from October 2018 to September 2022. Prior to Nurx and Thirty Madison, Ms. Watson was the Vice President of Marketing at experience marketplace IfOnly (which became Mastercard Priceless Cities following the acquisition from Mastercard), from February 2014 to August 2018. Prior to IfOnly, Ms. Watson was Director of Marketing at multiple companies including Kabbage, now an American Express company, Shutterfly Inc., and LaQuinta Hotels, a Wyndham company, from February 2007 to February 2014. Ms. Watson has also served as marketing advisor in parallel to full time roles over time for many companies which include former roles at Quickframe, Galore, Fairy, and Minded and current roles at Pixis and BonBon. Ms. Watson holds a B.B.A. from the University of North Texas. |
• | Communications regarding individual grievances or other interests that are personal to the party submitting the communication; and |
• | Communications that contain offensive, obscene or abusive content. |
• | Update the trending of various enterprise risks; |
• | Identify and consider new and emerging risks; |
• | Assess the implementation status and effectiveness of each mitigation strategy; and |
• | Identify areas for improvement in the mitigation strategies, if any. |
• | To assist the Audit Committee with its risk assessment function, Internal Audit has a direct communication channel to the Audit Committee for purposes of reporting or discussing concerns. |
• | Our Chief Legal Officer has a direct communication channel to the Audit Committee for purposes of discussing or reporting financial misconduct matters with the Audit Committee and/or its individual members. The Chief Legal Officer also provides periodic reports on the Company’s litigation matters. |
• | The Chief Compliance Officer provides periodic reports to the Audit Committee on the Company’s data privacy and information and infrastructure security programs, including cybersecurity. |
Board Diversity Matrix as of April 30, 2025 | ||||||||||||||
Total Number of Directors: 9 | ||||||||||||||
Gender: | Female | Male | Non-Binary | Did not Disclose Gender | ||||||||||
Directors: | 4 | 5 | 0 | 0 | ||||||||||
Demographic Information: | ||||||||||||||
African American or Black | 0 | 1 | 0 | 0 | ||||||||||
Alaskan Native or Native American | 0 | 0 | 0 | 0 | ||||||||||
Asian | 2 | 0 | 0 | 0 | ||||||||||
Hispanic or Latinx | 0 | 0 | 0 | 0 | ||||||||||
White | 2 | 4 | 0 | 0 | ||||||||||
Two or more races or Ethnicities | 0 | 0 | 0 | 0 | ||||||||||
LGBTQ+ | 1 | 0 | 0 | 0 | ||||||||||
Did not Disclose Demographic Background | 0 | 0 | 0 | 0 | ||||||||||
Name | Audit | Compensation | Nominating and Corporate Governance | ||||||
Michael Hansen | X | X | |||||||
Douglas Braunstein | |||||||||
Jon Cohen | |||||||||
Madhu Pawar | |||||||||
Erez Shachar | Chair | X | |||||||
Curtis Warfield | Chair | X | |||||||
Jacqueline Yeaney | X | Chair | |||||||
Swati Abbott | X | X | |||||||
Liat Ben-Zur | X | X | |||||||
• | appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm; |
• | discussing with our independent registered public accounting firm their independence; |
• | reviewing with our independent registered public accounting firm the scope and results of their audit; |
• | approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm; |
• | overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the interim and annual financial statements that we file with the SEC; |
• | overseeing the Company’s risk management process, with the support of the Chief Compliance Officer, CTO and CISO; |
• | discussing cybersecurity-related news, updates to our cybersecurity risk management and strategy program, and any material cybersecurity risks with management; |
• | reviewing related person transactions; |
• | overseeing our financial and accounting controls and compliance with legal and regulatory requirements; and |
• | establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting or auditing matters. |
• | reviewing and making recommendations to the Board regarding the compensation of our chief executive and other executive officers; |
• | reviewing and making recommendations to our Board regarding the compensation of our directors; |
• | overseeing risks related to our compensation programs; |
• | reviewing and approving or making recommendations to our Board regarding our incentive compensation and equity-based plans and arrangements; and |
• | appointing and overseeing any compensation consultants. |
• | identifying individuals qualified to become members of our Board, consistent with criteria approved by our Board, except where the Company is legally required by contract, bylaw or otherwise to provide third parties with the right to designate directors; |
• | recommending to our Board the nominees for election to our Board at annual meetings of stockholders, except where the Company is legally required by contract, bylaw or otherwise to provide third parties with the right to designate directors; |
• | overseeing an evaluation of the Board and its committees; and |
• | developing and recommending to our Board a set of corporate governance guidelines and principles. |
• | Jon Cohen, our Chief Executive Officer; |
• | Ian Harris, our Chief Financial Officer; |
• | Jennifer Fulk, our former Chief Financial Officer; |
• | Gil Margolin, our Chief Technology Officer; |
What We Do | What We Do Not Do | ||
Emphasize the use of equity compensation to promote executive retention and reward long-term value creation. | Do not guarantee annual salary increases. | ||
Weight the overall pay mix towards incentive compensation for senior executives. | Do not grant uncapped cash incentives or guaranteed equity compensation. | ||
Engage an independent compensation consultant to advise our Compensation Committee | Do not provide significant perquisites. | ||
Maintain rigorous stock ownership guidelines and a clawback policy. | Do not provide any compensation-related tax gross-up | ||
• | Attract and retain talented and experienced executives in a competitive and dynamic market; |
• | Motivate our NEOs to help our company achieve the best possible financial and operational results; |
• | Provide reward opportunities consistent with our performance on both a short-term and long-term basis that are industry-competitive, flexible, fiscally responsible, and linked to our overall business objectives; and |
• | Align the long-term interests of our NEOs with those of our stockholders. |
• | Base Salary. Base salary attracts and retains talented executives, recognizes individual roles and responsibilities, and provides compensation in respect of an executive’s day-to-day responsibilities; |
• | Annual Cash Incentive Compensation. Annual bonuses promote short-term performance objectives and reward executives for their contributions to Company performance; |
• | Equity Based Long-Term Incentive Compensation. Equity compensation, provided in the form of stock options and RSUs during 2024, aligns executives’ interests with our stockholders’ interests, emphasizes long-term financial and operational performance, and helps retain executive talent. |
Name | 2024 Annualized Base Salary at Year-End | ||
Jon Cohen | $600,000 | ||
Jennifer Fulk(1) | $400,000 | ||
Ian Harris(2) | $400,000 | ||
Gil Margolin | $400,000 | ||
(1) | The Company previously announced that Ms. Fulk would no longer serve as the Company’s Chief Financial Officer effective as of May 20, 2024. In connection therewith, the Company entered into a separation agreement with Ms. Fulk (the “Separation Agreement”). Pursuant to the terms of the Separation Agreement, Ms. Fulk received a severance payment equal to $400,000, representing her current annual base salary, to be paid over 12 months. |
(2) | Due to his start date of May 20, 2024, Mr. Harris was actually paid $247,000 of his annualized base salary of $400,000. |
Named Executive Officer | Target Percentage (as a Percentage of Base Salary)(3) | ||
Jon Cohen | 100% | ||
Jennifer Fulk(1) | 100% | ||
Ian Harris(2) | 100% | ||
Gil Margolin | 100% | ||
(1) | Pursuant to the terms of her Separation Agreement, the Company agreed to honor Ms. Fulk’s 2024 bonus at 50% of the total amount awarded (at least 100% of personal amount and up to 150% of the Company amount) with the caveat that in no event would it be less than $200,000. |
(2) | Pursuant to the terms of his Offer Letter, Mr. Harris’ 2024 bonus was pro-rated to account for his May 2024 hire date to 7/12ths of his target Annual Bonus, which going forward will be equal to 100% of his base annual salary. |
Name | Number of Shares Underlying Stock Options(1) | Number of RSUs(2) | ||||
Jon Cohen | 214,051 | 128,866 | ||||
Jennifer Fulk | 74,205(3) | 178,695(4) | ||||
Ian Harris | 0 | 311,250(5) | ||||
Gil Margolin | 27,399 | 65,980 | ||||
(1) | The stock options vest in 16 substantially equal installments on a quarterly basis, subject to the NEO’s continued service with the Company through each vesting date. |
(2) | The RSUs vest in 16 substantially equal installments on a quarterly basis, subject to the NEO’s continued service with the Company through each vesting date. |
(3) | All the stock options granted to Ms. Fulk were forfeited in connection with her separation from the Company and pursuant to the terms of her Separation Agreement. |
(4) | 89,347 of the RSUs granted to Ms. Fulk were forfeited in connection with her separation from the Company and pursuant to the terms of her Separation Agreement. |
(5) | Prior to his appointment as the Company's Chief Financial Officer, Mr. Harris was engaged by the Company in early 2024 as an independent consultant and pursuant to the terms of his Consulting Services Agreement, was awarded 11,250 RSUs as consideration for his consulting services. Upon the early termination of his Consulting Services Agreement and his appointment as the Company's Chief Financial Officer on May 20, 2024, 6,250 unvested RSUs were forfeited. |
Name | Principal Position | Year | Salary ($) | Bonus ($)(1) | Stock Awards ($)(2) | Option Awards ($)(2) | All Other Compensation ($)(3) | Total ($) | ||||||||||||||||
Jon Cohen | Chief Executive Officer | 2024 | 600,000 | 494,400 | 385,309 | 389,059 | 24,289 | 1,893,057 | ||||||||||||||||
2023 | 600,000 | 715,200 | — | — | 22,123 | 1,337,323 | ||||||||||||||||||
Ian Harris | Chief Financial Officer | 2024 | 233,000 | 219,733 | 800,950 | 0 | 30,598 | 1,281,423 | ||||||||||||||||
2023 | — | — | — | — | — | — | ||||||||||||||||||
Jennifer Fulk | Former Chief Financial Officer | 2024 | 153,000 | 200,000 | 1,008,958 | 37,779 | 430,744(4) | 1,830,481 | ||||||||||||||||
2023 | 400,000 | 476,800 | 378,420 | 86,879 | 31,005 | 1,373,104 | ||||||||||||||||||
Gil Margolin(4) | Chief Technology Officer | 2024 | 400,000 | 329,600 | 197,280 | 49,801 | 31,100 | 1,007,781 | ||||||||||||||||
2023 | 400,000 | 476,800 | 139,725 | 32,079 | 30,704 | 1,079,308 | ||||||||||||||||||
(1) | 2024 amounts represent discretionary annual bonus which were paid in February 2025. 2023 amounts represent discretionary annual bonus which was paid in February 2024. |
(2) | Amounts reflect the full grant-date fair value of restricted stock units and stock options granted during fiscal 2024 and 2023computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to calculate the value of all restricted stock units and option awards made to our NEOs in Note 2 and Note 10 to the consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024. |
(3) | Amounts represent matching contributions received under the Company’s 401(k) plan, the employer paid portion of medical premiums, life and accidental insurance and, short-term and long-term disability insurance. |
(4) | This amount includes separation payments in the amount of $400,000 in salary payments and $9,744 in COBRA payments paid to Ms. Fulk pursuant to the terms of her Separation Agreement. |
Name | Grant Date | Option Awards | Stock Awards | ||||||||||||||||||
Number of Securities Underlying Unexercised Options (#) Exercisable | Number of Securities Underlying Unexercised Options (#) Unexercisable | Option Exercise Price ($) | Option Expiration Date | Number of Shares or Units of Stock That Have Not Vested (#) | Market Value of Shares or Units of Stock That Have Not Vested ($)(1) | ||||||||||||||||
Jon Cohen | 9/26/2022(2) | 39,383 | $121,693 | ||||||||||||||||||
9/26/2022(3) | 100,105 | 100,106 | 1.00 | 9/24/2032 | |||||||||||||||||
12/1/2022(4) | 1,437,500 | $4,441,875 | |||||||||||||||||||
12/1/2022(5) | 325,000 | 575,000 | 0.86 | 11/30/2032 | |||||||||||||||||
3/1/2024 (6) | 104,704 | $323,535 | |||||||||||||||||||
3/1/2024(7) | 40,134 | 173,917 | 2.99 | 3/1/2034 | |||||||||||||||||
Ian Harris | 6/1/2024(8) | 300,000 | $927,000 | ||||||||||||||||||
Jennifer Fulk | 7/15/2021(9) | 338,662 | — | 5.81 | 3/30/2025 | ||||||||||||||||
3/1/2022(9) | 61,699 | — | 1.61 | 3/30/2025 | |||||||||||||||||
3/1/2023(9) | 38,092 | — | 0.88 | 3/30/2025 | |||||||||||||||||
Gil Margolin | 7/15/2021(10) | 402,187 | 92,813 | 5.81 | 7/14/2031 | ||||||||||||||||
10/18/2021(11) | 23,204 | $71,700 | |||||||||||||||||||
3/1/2022(12) | 2,849 | 14,239 | 1.61 | 2/28/2032 | |||||||||||||||||
3/1/2022(13) | 39,736 | $122,784 | |||||||||||||||||||
3/1/2023(14) | — | 31,647 | 0.88 | 2/28/2033 | |||||||||||||||||
3/1/2023(15) | 89,619 | $276,923 | |||||||||||||||||||
3/1/2024(7) | 5,136 | 22,263 | 2.99 | 3/1/2034 | |||||||||||||||||
3/1/2024(6) | 53,609 | $165,652 | |||||||||||||||||||
(1) | Amounts are calculated based on multiplying the number of shares shown in the table by the per share closing price of our common stock on December 31, 2024, which was $3.09. |
(2) | These RSU awards, which were granted under the 2021 Plan, vest over a four-year period on each anniversary of June 22, 2022, subject to the NEO’s continued employment through each such vesting date. |
(3) | These stock options, which were granted under the 2021 Plan, vest and become exercisable in four equal installments on each anniversary of June 22, 2022, subject to the NEO’s continued employment through each such vesting date. |
(4) | 1,250,000 RSU awards, which were granted under the 2021 Plan, vest 25% on the one-year anniversary of December 1, 2022 and 75% in twelve equal installments on each of the first twelve quarterly anniversaries of December 1, 2023 thereafter, subject to the NEO’s continued employment through each such vesting date. 1,000,000 RSU awards, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2024, subject to the NEO’s continued employment through each such vesting date. |
(5) | 500,000 stock options, which were granted under the 2021 Plan, vest and became exercisable 25% on the one-year anniversary of December 1, 2022 and 75% in twelve equal installments on each of the first twelve quarterly anniversaries of December 1, 2023 thereafter, subject to the NEO’s continued employment through each such vesting date. 400,000 stock options, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2024, subject to the NEO’s continued employment through each such vesting date. |
(6) | These RSU awards, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2024, subject to the NEO’s continued employment through each such vesting date. |
(7) | These stock options, which were granted under the 2021 Plan, vest and become exercisable in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2024 thereafter, subject to the NEO’s continued employment through each such vesting date. |
(8) | These RSU awards, which were granted under the 2021 Plan, vest over a four-year period on each anniversary of June 1, 2024, subject to the NEO’s continued employment through each such vesting date. |
(9) | These stock options, which were granted under the 2021 Plan are fully vested as part of Jennifer Fulk's separation agreement |
(10) | These stock options, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of July 1, 2021, subject to the NEO’s continued employment through each such vesting date. |
(11) | These RSU awards, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of September 1, 2021, subject to the NEO’s continued employment through each such vesting date. |
(12) | These stock options, which were granted under the 2021 Plan, vest and become exercisable in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2022 thereafter, subject to the NEO’s continued employment through each such vesting date. |
(13) | These RSU awards, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2022 thereafter, subject to the NEO’s continued employment through each such vesting date. |
(14) | These stock options, which were granted under the 2021 Plan, vest and become exercisable in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2023 thereafter, subject to the NEO’s continued employment through each such vesting date. |
(15) | These RSU awards, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2023 thereafter, subject to the NEO’s continued employment through each such vesting date. |
Name | Benefit | Termination Without Cause or for Good Reason / Cause (no Change in Control) ($) | Change in Control (no Termination) ($)(1) | Termination Without Cause or for Good Reason / Cause in Connection with a Change in Control ($) | ||||||||
Jon Cohen | Cash | 600,000 | — | 2,400,000 | ||||||||
Equity Acceleration | — | — | 6,395,966(2) | |||||||||
Continued Healthcare | 47,002 | — | 70,503 | |||||||||
Total(3) | 647,002 | — | 8,866,469 | |||||||||
Ian Harris | Cash | 400,000 | — | 1,600,000 | ||||||||
Equity Acceleration | — | — | 927,000(2) | |||||||||
Continued Healthcare | 47,002 | — | 70,503 | |||||||||
Total(3) | 447,002 | — | 2,597,503 | |||||||||
Jennifer Fulk | Cash | 600,000 | — | — | ||||||||
Equity Acceleration | 1,046,737 | — | — | |||||||||
Continued Healthcare | 9,744 | — | — | |||||||||
Total(3) | 1,656,481 | — | — | |||||||||
Gil Margolin | Cash | 400,000 | — | 1,600,000 | ||||||||
Equity Acceleration | — | — | 730,299(2) | |||||||||
Continued Healthcare | 47,002 | — | 70,503 | |||||||||
Total(3) | 447,002 | — | 2,400,802 | |||||||||
(1) | Pursuant to the 2021 Plan and the applicable award agreements, in the event of a change in control where an acquiror assumes, replaces or substitutes outstanding equity awards, awards under the 2021 Plan would not accelerate vesting. For purposes of the table above, we have assumed that awards are assumed, replaced or substituted in connection with the change in control. |
(2) | Assumes full acceleration of all unvested equity awards outstanding as of December 31, 2024. With respect to options, the value of equity acceleration was calculated by (i) multiplying the number of accelerated shares of common stock underlying the options by $2.54, the closing trading price of our common stock on December 29, 2023 and (ii) subtracting the exercise price for the options. No value is shown in respect of accelerated option shares with an exercise price that exceeds $2.54. With respect to RSUs, the value of equity acceleration was calculated by multiplying the number of accelerated RSUs by $2.54, the closing trading price of our common stock on December 29, 2023. |
(3) | Amounts shown are the maximum potential payment the NEO would have received as of December 31, 2024. The amounts of any reduction pursuant to the 280G best pay provision, if any, would be calculated upon actual termination of employment. |
(4) | Pursuant to the terms of Dr. Cohen’s offer letter, in the event he experiences a qualifying termination under the Severance Plan following the first anniversary of his start date, he will vest in a number of RSUs and stock options underlying the initial grant he received in December of 2022 that he would have otherwise vested in had he remained employed by the Company for the 12-month period immediately following his termination date, subject to his compliance with all other terms and conditions of the Severance Plan and his offer letter. |
Year | Summary Compensation Table Total for PEO ($)(1) | Compensation Actually paid to PEO ($)(2) | Average Summary Compensation Table Total for Non-PEO Named Executive Officers ($)(3) | Average Compensation Actually Paid to Non-PEO Named Executive Officers ($)(4) | Value of Initial Fixed $100 investment based on Total Shareholder Return ($)(5) | Net Income (Loss) in Thousands ($)(6) | ||||||||||||||||||
(a) | (b) | (c) | (b) | (c) | (d) | (e) | (f) | (g) | ||||||||||||||||
2024 | ||||||||||||||||||||||||
2023 | ( | |||||||||||||||||||||||
2022 | ( |
(1) | The dollar amounts reported in column (b) are the amounts of Total compensation reported for |
(2) | The dollar amounts reported in columns (b) for 2023 represent the amount of “compensation actually paid” to Mr. Cohen for 2024. The dollar amounts reported in columns (b) for 2023 represent the amount of “compensation actually paid” to Mr. Cohen. The dollar amounts reported in columns (b) and (c) 2022 represent the amount of “compensation actually paid” to Mr. Cohen and Mr. Braunstein and, respectively, as computed in accordance with Item 402(v) of Regulation S-K for such year. The dollar amounts do not reflect the actual amount of compensation earned by or paid to these executives during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to total compensation for 2024 to determine the compensation actually paid to Mr. Cohen for 2023: |
Year | Reported Summary Compensation Table Total for PEO 1 (Mr. Cohen) | Deduct Reported Value of Equity Awards | Equity Award Adjustments(a) | Compensation Actually Paid to PEO 1 (Mr. Cohen) | ||||||||
2024 | $ | $( | $ | $ | ||||||||
(a) | The amounts deducted or added in calculating the total average equity award adjustments are as follows: |
Year (PEO 1) | Year End Fair Value of Equity Awards Outstanding and Unvested Granted in the Year | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior years | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year | Change in Fair Value as of Vesting Date of Equity Awards Granted in Prior Years that Vested in the Year | Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year | Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation | Total Equity Award Adjustments | ||||||||||||||
2024 | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||
(3) | The dollar amounts reported in column (d) represent the average of the amounts reported for the Company’s non-CEO named executive officers (NEOs) as a group in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the non-CEO NEOs included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2023, Ms. Fulk and Gil Margolin; (ii) for 2022, Ms. Jennifer Fulk and Messrs. Gil Margolin and John Reilly; and (iii) for 2021, Ms. Jennifer Fulk, Ms. Samara Braunstein, Ms. Roni Frank, and Messrs. Mark Hirschhorn, Gil Margolin, and John Reilly. |
(4) | The dollar amounts reported in column (e) represent the average amount of “compensation actually paid” to the non-CEO NEOs as a group, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to these NEOs as a group during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the non-CEO NEOs as a group for each year to determine the compensation actually paid, using the same methodology described above in Note 2: |
Year | Average Reported Summary Compensation Table Total for Non-PEO NEOs | Deduct Average Reported Value of Equity Awards | Average Equity Award Adjustments(a) | Average Compensation Actually Paid to Non-PEO NEOs | ||||||||
2024 | $ | $( | $ | $ | ||||||||
(a) | The amounts deducted or added in calculating the total average equity award adjustments are as follows: |
Year | Average Year End Fair Value of Equity Awards Outstanding and Unvested Granted in the Year | Year over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards | Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year | Average Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year | Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year | Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation | Total Average Equity Award Adjustments | ||||||||||||||
2024 | $ | $ | $ | $ | $( | $ | $ | ||||||||||||||
(5) | Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period. |
(6) | The dollar amounts reported represent the amount of net income reflected in the Company’s audited financial statements for the applicable year. |
Plan category: | Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants, and Rights and Vesting of Stock Awards(1) | Weighted-Average Exercise Price of Outstanding Options, Warrants, and Rights | Number of Securities Available for Future Issuance Under Equity Compensation Plans (excludes securities Reflected in first column)(2) | ||||||
Equity compensation plans not approved by security holders | — | — | — | ||||||
Equity compensation plans approved by security holders | 16,752,170 | $2.93 | 9,853,652 | ||||||
Total | 16,752,170 | $2.93 | 9,853,652 | ||||||
Name | Fees Earned or Paid in Cash ($) | Option Awards ($)(1)(3) | Stock Awards ($)(1)(6) | Total ($) | ||||||||
Douglas L. Braunstein | 70,000(2) | — | 160,189 | 230,189 | ||||||||
Erez Shachar | 50,000(3) | — | 160,189 | 210,189 | ||||||||
Curtis Warfield | 60,000 | — | 160,189 | 220,189 | ||||||||
Jacqueline Yeaney | 40,000 | — | 160,189 | 200,189 | ||||||||
Madhu Pawar | 40,000(4) | — | 160,189 | 200,189 | ||||||||
Michael Hansen | 40,000 | — | 160,189 | 200,189 | ||||||||
Liat Ben-Zur | 40,000 | — | 160,189 | 200,189 | ||||||||
Swati Abbott | 40,000(5) | — | 160,189 | 200,189 | ||||||||
(1) | Amounts reflect the full grant-date fair value of RSUs and stock options granted during 2024 computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to calculate the value of all RSUs and option awards made to our directors in Note 10 to the consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024. |
(2) | Mr. Brauntsein elected to receive his cash retainer fees payable in the form of RSUs. As a result, Mr. Braunstein was granted: (i) 6,014 RSUs on March 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $17,982, (ii) 6,406 RSUs on June 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $16,784, (iii) 9,440 RSUs on September 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $18,80, and (iv) 5,123 RSUs on December 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $17,521. |
(3) | Mr. Shachar elected to receive his cash retainer fees payable in the form of RSUs. As a result, Mr. Shachar was granted: (i) 4,296 RSUs on March 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $12,845, (ii) 4,576 RSUs on June 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $11,989, (iii) 6,743 RSUs on September 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $13,486, and (iv) 3,660 RSUs on December 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $12,517. |
(4) | Ms. Pawar elected to receive her cash retainer fees payable in the form of RSUs. As a result, Ms. Pawar was granted: (i) 3,437 RSUs on March 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $10,277, (ii) 3,661 RSUs on June 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $9,592, (iii) 5,394 RSUs on September 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $10,788, and (iv) 2,928 RSSUs on December 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of 10,014. |
(5) | Ms. Abbott elected to receive her cash retainer fees payable in the form of RSUs. As a result, Ms. Abbott was granted: (i) 3,437 RSUs on March 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $10,277, (ii) 3,661 RSUs on June 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $9,592, (iii) 5,394 RSUs on September 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $10,788, and (iv) 2,928 RSSUs on December 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of 10,014. |
(6) | The table below shows the aggregate numbers of option awards (exercisable and unexercisable) and unvested stock awards held as of December 31, 2024 by each non-employee director. |
Name | Option Awards Outstanding at 2024 Fiscal Year End | Unvested Stock Awards Outstanding at 2024 Fiscal Year End | ||||
Jon R. Cohen(1) | 1,314,262 | 1,581,587 | ||||
Douglas L. Braunstein | 703,402 | 50,685 | ||||
Erez Shachar | 63,402 | 50,685 | ||||
Curtis Warfield | 63,402 | 50,685 | ||||
Jacqueline Yeaney | 63,402 | 50,685 | ||||
Madhu Pawar | 63,402 | 50,685 | ||||
Michael Hansen | 200,211 | 86,222 | ||||
Swati Abbott | 57,985 | 92,751 | ||||
Liat Ben-Zur | 57,985 | 92,751 | ||||
(1) | Dr. Cohen serves as our Chief Executive Officer since November 2022; as such, his compensation earned as a director is disclosed in the Summary Compensation Table and his outstanding equity awards are disclosed in the Outstanding Equity Awards at Fiscal Year End table. |
• | Annual Retainer: $40,000 |
• | Annual Committee Chair Retainer: |
○ | Audit: $20,000 |
○ | Compensation: $10,000 |
• | Annual Chairman Retainer: $30,000 |
• | stockholders who beneficially own more than 5% of the outstanding shares of our common stock; |
• | each of our directors and director nominees; |
• | each of our NEOs; and |
• | all of our executive officers and directors as a group. |
Name and Address of Beneficial Owner | Number of Shares(1) | % of Ownership | ||||
5% Holders | ||||||
HEC Master Fund LP(2) | 23,525,046 | 14.14% | ||||
Norwest Venture Partners XIII, LP(3) | 14,702,972 | 8.8% | ||||
Goldman Sachs Group, Inc.(4) | 8,355,680 | 5.0% | ||||
Qumra Capital II, L.P.(5) | 8,573,437 | 5.1% | ||||
Directors and Named Executive Officers | ||||||
Jon Cohen(6) | 1,590,754 | 1.0% | ||||
Ian Harris(7) | 219,518 | * | ||||
Gil Margolin(8) | 520,366 | * | ||||
Douglas L. Braunstein(9) | 25,834,742 | 15.8% | ||||
Erez Shachar(10) | 88,620,988 | 5.2% | ||||
Curtis Warfield(11) | 200,026 | * | ||||
Jacqueline Yeaney(12) | 305,476 | * | ||||
Madhu Pawar(13) | 324,483 | * | ||||
Michael Hansen(14) | 217,842 | * | ||||
Swati Abbott(15) | 45,219 | * | ||||
Liat Ben-Zur(16) | 14,496 | * | ||||
All current directors and executive officers as a group (13 individuals)(14) | 39,398,142 | 23.5% | ||||
* | Less than 1% |
(1) | Shares of common stock beneficially owned for the directors and executive officers includes shares of common stock held as of the date of the table, stock options that are vested as of the date of the table, and stock options and RSUs that will vest within 60 days following the date of the table. |
(2) | Based on information reported on a Schedule 13D/A filed on November 17, 2021, a Form 4 filed on March 5, 2024 and information known to the Company, consists of (i) 11,340,600 shares of common stock and 7,640,000 shares of common stock issuable upon the exercise of warrants held by HEC Master Fund LP, (ii) 2,274,446 shares of common stock owned jointly among Douglas Braunstein and his spouse (Samara Braunstein), including through a trust, (iii) 1,963,223 shares of common stock held directly by Mr. Braunstein, (iv) 687,551,760 shares of common stock held directly by Mr. Braunstein issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025 and (v) 2,270,000 shares of common stock beneficially owned jointly among Mr. Braunstein and his spouse (Samara Braunstein) through the ownership of warrants exercisable within 60 days of the date of April 21, 2025. Douglas Braunstein is the Managing Member of HEC Management GP LLC (“MGT GP”). MGT GP is the Managing Member of HEC Performance GP LLC and the Managing Partner of Hudson Executive Capital LP, which is the Investment Manager of the HEC Master Fund LP. Hudson Executive Capital LP and Mr. Braunstein disclaims beneficial ownership of the securities owned by HEC Master Fund LP except to the extent of his pecuniary interest therein. The address of HEC Master Fund LP is c/o Walkers Corporate Limited, 190 Elgin Avenue George Town, Grand Cayman KY1-9001. |
(3) | Based on information reported on a Schedule 13G filed on February 14, 2024, consists of shares of common stock held by Norwest Venture Partners XIII, LP (“NVP XIII”). Genesis VC Partners XIII, LLC is the general partner of NVP XIII and may be deemed to have sole voting and dispositive power over the shares held by NVP XIII. NVP Associates, LLC, the managing member of Genesis VC Partners XIII, LLC and each of Promod Haque, Jeffrey Crowe and Jon Kossow, as Co-Chief Executive Officers of NVP Associates, LLC and members of the general partner, may be deemed to share voting and dispositive power over the shares held by NVP XIII. Such persons and entities disclaim beneficial ownership of the shares held by NVP XIII, except to the extent of any proportionate pecuniary interest therein. |
(4) | Based on information reported on a Schedule 13G filed on February 9, 2024, consists of shares of common stock held by the Goldman Sachs Group, Inc. (“GS Group”) and Goldman Sachs & Co. LLC (“Goldman Sachs”). GS Group is the parent holding company of GS LLC, and thus these shares may be deemed to be beneficially owned by Goldman Sachs and Goldman Sachs may be deemed to have sole voting and dispositive power over the shares held by GS Group The address of Goldman Sachs is 200 West Street New York, NY 10282. |
(5) | Based on information reported on a Schedule 13D filed on July 1, 2021, consists of shares of common stock held by Qumra Capital II, L.P (“Qumra II”). Qumra Capital GP II, L.P. (“Qumra GP II”) is the general partner of Qumra II and Qumra Capital Israel I Ltd. (“Qumra Capital Ltd.”) is the general partner of Qumra GP II. Boaz Dinte and Erez Shachar serve as the managing partners of Qumra Capital Ltd. and share voting and dispositive power with respect to the shares held by Qumra II. Mr. Shachar serves as a member of our board of directors. The address for these entities is c/o Qumra Capital, HaNevi’im St 4, Tel Aviv-Yafo, Israel. |
(6) | Consists of (i) 781,471 shares of common stock and (ii) 809,283 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. |
(7) | Consists of (i) 128,481 shares of common stock and (ii) 91,037 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. |
(8) | Consists of (i) 0 shares of common stock and (ii) 520,366 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. |
(9) | See footnote 2. |
(10) | Consists of shares of (i) common stock held by Qumra II, (ii) 0 shares of common stock held by Mr. Shachar and (iii) 47,551 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. Mr. Shachar disclaims beneficial ownership of the shares held of record by Qumra II except to the extent of his pecuniary interest therein. See footnote 5. |
(11) | Consists of (i) 152,475 shares of common stock and (ii) 47,551 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. |
(12) | Consists of (i) 257,925 shares of common stock and (ii) 47,551 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. |
(13) | Consists of (i) 276,932 shares of common stock and (ii) 47,551 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. |
(14) | Consists of (i) 117,737 shares of common stock and (ii) 100,105 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. |
(15) | Consists of (i) 30,723 shares of common stock and (ii) 14,496 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. |
(16) | Current directors and executive officers as a group includes the named executive officers and current directors listed in the table above, as well as Mr. John Reilly and Ms. Katelyn Watson. For Mr. Reilly, consists of (i) 666,596 shares of common stock and (ii) 362,321 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. For Ms. Watson, consists of 100,362 shares of common stock and (ii) 33,875 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. |